Outsourcing channel feed

Vec­tura leans in­to new role as in­hala­tion CD­MO post-asth­ma flop with plant ex­pan­sion

5 years ago
Manufacturing

Look­ing for an edge in vac­cines, Ther­mo Fish­er plots ma­jor ex­pan­sions across glob­al man­u­fac­tur­ing sites in its port­fo­lio

5 years ago
Manufacturing

Pe­ter Thiel's Palan­tir scores con­tract with the FDA to speed up reg­u­la­to­ry re­views as de­lays keep grow­ing

5 years ago
Deals

Seat­tle's AGC plots $194M in­vest­ment to dou­ble pro­duc­tion at Copen­hagen site in busy year for bi­o­log­ics

5 years ago
Pharma
Coronavirus

KBI plans $150M fa­cil­i­ty in Re­search Tri­an­gle Park with mys­tery co-in­vestor

5 years ago

Af­ter Ko­dak de­ba­cle, US lends $1.1B to a syn­thet­ic bi­ol­o­gy com­pa­ny and their big Covid-19, mR­NA plans

5 years ago
Coronavirus

Bax­ter con­tin­ues on-shoring push with $50M In­di­ana ex­pan­sion

5 years ago
Pharma

Ko­re­a's Cell­tri­on in­vests $453M in­to new man­u­fac­tur­ing plant, re­search cen­ter

5 years ago
Manufacturing

Un­der a new CEO, Ger­man CD­MO Viba­log­ics bets $150M and 110,000 square feet on the gene ther­a­py rev­o­lu­tion

5 years ago
Cell/Gene Tx

En­do Phar­ma­ceu­ti­cals chops 560 jobs to re­fo­cus on cel­lulite drug launch

5 years ago
Pharma

FDA scut­tles blue­bird's ac­cel­er­at­ed plans for sick­le cell gene ther­a­py, as high­er CMC bar forces 1-year de­lay

5 years ago
Cell/Gene Tx
FDA+

No­var­tis CEO Vas Narasimhan signs off on a $231M deal to try some­thing new in the R&D fight against SARS-CoV-2

5 years ago
Deals
Coronavirus

Roche finds a home for a new, $500M man­u­fac­tur­ing lo­gis­tics hub, promis­ing 500 jobs

5 years ago
People
Pharma

Af­ter years of short­ages, Mer­ck an­nounces plans for a new fac­to­ry for an old life­sav­ing drug

5 years ago

Eli Lil­ly takes a one-two punch as Covid-19 an­ti­body com­bo study is halt­ed and man­u­fac­tur­ing ops fail in­spec­tion

5 years ago
Coronavirus

Ran­somware at­tack hit clin­i­cal tri­als soft­ware play­er ERT — two weeks lat­er, they’re com­ing back on­line

5 years ago
Pharma

Scoop: ARCH’s Bob Nelsen is back­ing an mR­NA up­start that promis­es to up­end the en­tire man­u­fac­tur­ing side of the glob­al busi­ness

5 years ago
Cell/Gene Tx

Sam­sung Bi­o­log­ics nets $330M+ deal from As­traZeneca ahead of 'Su­per Plan­t' con­struc­tion

5 years ago

Sam­sung con­struct­ing new $2B 'Su­per Plan­t' rough­ly the size of Amer­i­ca's largest malls

5 years ago
Pharma

Covid-19 roundup: Cure­Vac beefs up its uni­corn IPO dreams as bil­lion­aire own­er takes this Covid-19 mR­NA play­er on a forced march to Nas­daq; Ko­dak's $765M deal is put on hold

5 years ago
Pharma
Coronavirus

FDA takes the lead on defin­ing es­sen­tial un­der Trump's 'Buy Amer­i­can' ex­ec­u­tive or­der — as phar­ma warns of sup­ply chain dis­rup­tion

5 years ago
Pharma
FDA+

Trump reach­es for his pen as long-await­ed ex­ec­u­tive or­der on drug man­u­fac­tur­ing on-shoring fi­nal­ly ar­rives — re­ports

5 years ago
Pharma

Meet the lat­est ge­nom­ic da­ta com­pa­ny — aka WuXi NextCODE with­out the Chi­na op­er­a­tions

5 years ago
China

Fu­ji­film dou­bles down on ex-Bio­gen fa­cil­i­ty with $928M in­fu­sion as biotech boom fu­els CD­MO growth

5 years ago
First page Previous page 345678 Next page Last page
A service from the Financial Times